1. Home
  2. ABCL vs AIO Comparison

ABCL vs AIO Comparison

Compare ABCL & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • AIO
  • Stock Information
  • Founded
  • ABCL 2012
  • AIO 2019
  • Country
  • ABCL Canada
  • AIO United States
  • Employees
  • ABCL N/A
  • AIO N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • AIO Finance/Investors Services
  • Sector
  • ABCL Health Care
  • AIO Finance
  • Exchange
  • ABCL Nasdaq
  • AIO Nasdaq
  • Market Cap
  • ABCL 772.9M
  • AIO 826.9M
  • IPO Year
  • ABCL 2020
  • AIO N/A
  • Fundamental
  • Price
  • ABCL $2.03
  • AIO $21.54
  • Analyst Decision
  • ABCL Buy
  • AIO
  • Analyst Count
  • ABCL 3
  • AIO 0
  • Target Price
  • ABCL $7.50
  • AIO N/A
  • AVG Volume (30 Days)
  • ABCL 4.1M
  • AIO 141.5K
  • Earning Date
  • ABCL 05-08-2025
  • AIO 01-01-0001
  • Dividend Yield
  • ABCL N/A
  • AIO 9.05%
  • EPS Growth
  • ABCL N/A
  • AIO N/A
  • EPS
  • ABCL N/A
  • AIO N/A
  • Revenue
  • ABCL $23,114,000.00
  • AIO N/A
  • Revenue This Year
  • ABCL N/A
  • AIO N/A
  • Revenue Next Year
  • ABCL $36.62
  • AIO N/A
  • P/E Ratio
  • ABCL N/A
  • AIO N/A
  • Revenue Growth
  • ABCL N/A
  • AIO N/A
  • 52 Week Low
  • ABCL $1.89
  • AIO $15.09
  • 52 Week High
  • ABCL $4.34
  • AIO $20.25
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 34.87
  • AIO 60.47
  • Support Level
  • ABCL $1.98
  • AIO $21.07
  • Resistance Level
  • ABCL $2.64
  • AIO $21.67
  • Average True Range (ATR)
  • ABCL 0.14
  • AIO 0.42
  • MACD
  • ABCL -0.06
  • AIO 0.22
  • Stochastic Oscillator
  • ABCL 7.14
  • AIO 91.24

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

Share on Social Networks: